Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 366-369

  Onoda, Masahiko ^a   Yoshimura, Koichi ^b   Aoki, Hiroki ^b   Ikeda, Yasuhiro ^b   Morikage, Noriyasu ^a   Furutani, Akira ^a   Matsuzaki, Masunori ^b   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Abdominal aortic aneurysm; Inflammation; Lysyl oxidase; Monocyte chemoattractant protein 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN LYSINE 6 OXIDASE;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; EXPERIMENTAL MOUSE; EXTRACELLULAR MATRIX; GENE FUNCTION; GENE OVEREXPRESSION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; CHEMOKINE CCL2; CYTOKINES; DISEASE PROGRESSION; INFLAMMATION; MACROPHAGES; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; PROTEIN-LYSINE 6-OXIDASE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 74749083638     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.07.036     Document Type: Article

References (20)

1. Kagan H.M., and Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88 (2003) 660-672
2. Payne S.L., Hendrix M.J.C., and Kirschmann D.A. Paradoxical roles for lysyl oxidases in cancer - A prospect. J Cell Biochem 101 (2007) 1338-1354
3. Rodriguez C., Martinez-Gonzalez J., Raposo B., et al. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res 79 (2008) 7-13
4. Yoshimura K., Aoki H., Ikeda Y., et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 11 (2005) 1330-1338
5. Thompson R.W., Geraghty P.J., and Lee J.K. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr Probl Surg 39 (2002) 110-230
6. Huffman M.D., Curci J.A., Moore G., et al. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128 (2000) 429-438
7. Yamada M., Ikeda Y., Yano M., et al. Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy. FASEB J 20 (2006) 1197-1199
8. Aoki H., Kang P.M., Hampe J., et al. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 277 (2002) 10244-10250
9. Adachi M., Katsumura K.R., Fujii K., et al. Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells. FEBS Lett 554 (2003) 77-80
10. Palamakumbura A.H., and Trackman P.C. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem 300 (2002) 245-251
11. Longo G.M., Xiong W., Greiner T.C., et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
12. Nomura S., Yoshimura K., Akiyama N., et al. HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins. Eur Surg Res 37 (2005) 370-378
13. Chen Y.M., Chiang W.C., Lin S.L., et al. Dual regulation of tumor necrosis factor-α-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-κB and activator protein-1: Modulation by type III phosphodiesterase inhibition. J Pharmacol Exp Ther 309 (2004) 978-986
14. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 6 (2005) 1191-1197
15. Kudo J., Yoshimura K., and Hamano K. Simvastatin reduces secretion of monocyte chemoattractant proteins and matrix metalloproteinase-9 in human abdominal aortic aneurysms. Bull Yamaguchi Med School 54 (2007) 47-56
16. Colonnello J.S., Hance K.A., Shames M.L., et al. Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm. J Vasc Surg 38 (2003) 138-146
17. Ishibashi M., Egashira K., Zhao Q., et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24 (2004) e174-178
18. Lucero H.A., Ravid K., Grimsby J.L., et al. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells. J Biol Chem 283 (2008) 24103-24117
19. Isenburg J.C., Simionescu D.T., Starcher B.C., and Vyavahare N.R. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation 115 (2007) 1729-1737
20. Rodriguez C., Alcudia J.F., Martinez-Gonzalez J., et al. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors. Cardiovasc Res 83 (2009) 595-603